Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey
Muskan Israni(Royal Free London NHS Foundation Trust), L. Marques(Universitat Autònoma de Barcelona), Carine Wouters(KU Leuven), Siobhan O. Burns(Royal Free London NHS Foundation Trust), Andrew R. Gennery(Hôpital Necker-Enfants Malades), Stephanie Skeffington, Benson Ogunjimi(University College London), Alessandro Plebani(University of Brescia), Marija Jelušić(University Hospital Centre Zagreb), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Jan van Laar(Erasmus MC), Mojca Zajc Avramovič(Ljubljana University Medical Centre), Jordi Antón, Anna Šedivá(Charles University), Virgil A. S. H. Dalm(Erasmus MC), Š. Fingerhutová(University College London), Maria Carrabba(Leeds Teaching Hospitals NHS Trust), Linda Rossi‐Semerano(Assistance Publique – Hôpitaux de Paris), Klaus Warnatz(University of Freiburg), Aurélien Guffroy(Inserm), Kristiina Aalto, Isabelle Meyts(KU Leuven), Viviana Moschese(University of Rome Tor Vergata), Julia Nordin, Rachel Rimmer(Network Rail), Mari Campbell(Royal Free London NHS Foundation Trust), L. Goffin(Universitat Autònoma de Barcelona), Nico Wulffraat(Wilhelmina Children's Hospital), Jutte E. van der Werff ten Bosch, Troels Herlin(Sahlgrenska University Hospital), Nizar Mahlaoui(Hôpital Necker-Enfants Malades), R. Cimaz(University College London), Georgia Hayward(Leeds General Infirmary), Anne‐Sophie Korganow(Inserm), Carlotta Villar, Clementina Canessa(Universitat Autònoma de Barcelona), Marco Cattalini(University of Brescia), Laura Obici(Amyloidosis Foundation), Antonella Insalaco(Bambino Gesù Children's Hospital), Federica Barzaghi(The San Raffaele Telethon Institute for Gene Therapy), H. Ritterbusch(University College London), Rosa Maria Dellepiane(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Bethany Nicholson(Royal Free London NHS Foundation Trust), Leire Solís, J. Kelečić(Hospital Sant Joan de Déu Barcelona), Stephan Berg(Sahlgrenska University Hospital), Pere Soler‐Palacín(Universitat Autònoma de Barcelona), Tania Amin(Leeds Teaching Hospitals NHS Trust), O. Gilliaux(University College London)
Cited by 27
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951